variables: 816987
Data license: CC-BY
This data as json
id | name | unit | description | createdAt | updatedAt | code | coverage | timespan | datasetId | sourceId | shortUnit | display | columnOrder | originalMetadata | grapherConfigAdmin | shortName | catalogPath | dimensions | schemaVersion | processingLevel | processingLog | titlePublic | titleVariant | attributionShort | attribution | descriptionShort | descriptionFromProducer | descriptionKey | descriptionProcessing | licenses | license | grapherConfigETL | type | sort | dataChecksum | metadataChecksum |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
816987 | New bacteriologically confirmed pulmonary tuberculosis cases with rifampicin resistance | new patients with rifampicin resistance | 2023-12-05 11:51:59 | 2024-07-25 22:54:10 | 2017-2022 | 6308 | { "unit": "new patients with rifampicin resistance", "numDecimalPlaces": 0 } |
0 | rr_new | grapher/tuberculosis/2023-11-27/drug_resistance_surveillance/drug_resistance_surveillance#rr_new | 2 | major | Number of new bacteriologically confirmed pulmonary tuberculosis cases with rifampicin resistance. Rifampicin is an antibiotic medication used primarily in the treatment of tuberculosis and other bacterial infections; it works by inhibiting the growth of bacteria. | Number of new bacteriologically confirmed pulmonary tuberculosis patients with resistance to rifampicin (RR-tuberculosis). | [] |
int | [] |
9f4348facce727a1730635922e37d131 | 8e572d113d90f43f6009a69c5f55315b |